| EMA | European Medicines Agency |
| FDA | Food and Drug Administration |
| LEN | Lenacapavir |
| PLWH | People living with HIV |
| CVF | Confirmed virologic failure |
| LA | Long-acting |
| ISR | Injection site reaction |
| TND | Target not detected |
| CAB/RPV | Cabotegravir/rilpivirine |
| TAF | Tenofovir alafenimide |
| BIC | Bictegravir |
| BL | Baseline |